• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分泌型白细胞蛋白酶抑制剂(SLPI)对心脏移植中缺血/再灌注损伤的影响。

The effect of secretory leukocyte protease inhibitor (SLPI) on ischemia/reperfusion injury in cardiac transplantation.

作者信息

Schneeberger S, Hautz T, Wahl S M, Brandacher G, Sucher R, Steinmassl O, Steinmassl P, Wright C D, Obrist P, Werner E R, Mark W, Troppmair J, Margreiter R, Amberger A

机构信息

D. Swarovski Research Laboratory, Department of General and Transplant Surgery, Innsbruck Medical University, Innsbruck, Austria.

出版信息

Am J Transplant. 2008 Apr;8(4):773-82. doi: 10.1111/j.1600-6143.2008.02158.x. Epub 2008 Feb 19.

DOI:10.1111/j.1600-6143.2008.02158.x
PMID:18294346
Abstract

We investigated the role of secretory leukocyte protease inhibitor (SLPI) in ischemia/reperfusion injury in cardiac transplantation. SLPI-/- mouse hearts and wild-type (WT) controls were transplanted immediately or after 10 h of cold ischemia (CI). Recombinant SLPI (rSLPI) was added to the preservation solution or given systemically. After evaluation of myocardial performance, grafts were investigated for histology, SLPI, TNF-alpha, TGF-beta, NF-kappaB and protease expression at indicated time points. Early myocardial contraction was profoundly impaired in SLPI-/- hearts exposed to CI and associated with high intra-graft protease expression. Systemic administration of rSLPI had no effect, however, when SLPI was added to the preservation solution, myocardial contraction was restored to normal. At 10 days, inflammation, myocyte vacuolization and necrosis were significantly more severe in SLPI-/- hearts. SLPI gene expression was detected in WT mice at 12 and 24 h and was significantly higher after CI. SLPI protein was observed at 24 h and 10 days. High intra-graft concentrations of SLPI after administration of rSLPI were inversely correlated with protease levels early and TGF-beta expression late after reperfusion. SLPI plays a crucial role in early myocardial performance and postischemic inflammation after cardiac transplantation. A dual inhibitory effect on protease and TGF-beta expression might be the underlying mechanism.

摘要

我们研究了分泌型白细胞蛋白酶抑制剂(SLPI)在心脏移植缺血/再灌注损伤中的作用。将SLPI基因敲除小鼠心脏和野生型(WT)对照立即移植,或在冷缺血(CI)10小时后移植。将重组SLPI(rSLPI)添加到保存液中或进行全身给药。在评估心肌功能后,在指定时间点对移植物进行组织学、SLPI、肿瘤坏死因子-α(TNF-α)、转化生长因子-β(TGF-β)、核因子-κB(NF-κB)和蛋白酶表达的研究。暴露于CI的SLPI基因敲除小鼠心脏早期心肌收缩严重受损,且与移植物内高蛋白酶表达相关。然而,rSLPI全身给药无效,而当将SLPI添加到保存液中时,心肌收缩恢复正常。在第10天,SLPI基因敲除小鼠心脏的炎症、心肌细胞空泡化和坏死明显更严重。在WT小鼠中于12小时和24小时检测到SLPI基因表达,CI后显著升高。在24小时和10天时观察到SLPI蛋白。给予rSLPI后移植物内高浓度的SLPI与再灌注早期的蛋白酶水平及晚期的TGF-β表达呈负相关。SLPI在心脏移植后的早期心肌功能和缺血后炎症中起关键作用。对蛋白酶和TGF-β表达的双重抑制作用可能是其潜在机制。

相似文献

1
The effect of secretory leukocyte protease inhibitor (SLPI) on ischemia/reperfusion injury in cardiac transplantation.分泌型白细胞蛋白酶抑制剂(SLPI)对心脏移植中缺血/再灌注损伤的影响。
Am J Transplant. 2008 Apr;8(4):773-82. doi: 10.1111/j.1600-6143.2008.02158.x. Epub 2008 Feb 19.
2
Secretory leukocyte protease inhibitor gene deletion alters bleomycin-induced lung injury, but not development of pulmonary fibrosis.分泌型白细胞蛋白酶抑制剂基因缺失改变博来霉素诱导的肺损伤,但不影响肺纤维化的发展。
Lab Invest. 2016 Jun;96(6):623-31. doi: 10.1038/labinvest.2016.40. Epub 2016 Mar 14.
3
Overexpression and pre-treatment of recombinant human Secretory Leukocyte Protease Inhibitor (rhSLPI) reduces an in vitro ischemia/reperfusion injury in rat cardiac myoblast (H9c2) cell.重组人分泌型白细胞蛋白酶抑制剂(rhSLPI)的过表达和预处理可减轻大鼠心肌成肌细胞(H9c2)的体外缺血/再灌注损伤。
Biomol Concepts. 2018 May 4;9(1):17-32. doi: 10.1515/bmc-2018-0004.
4
Secretory leukocyte protease inhibitor in mice regulates local and remote organ inflammatory injury induced by hepatic ischemia/reperfusion.小鼠中的分泌型白细胞蛋白酶抑制剂可调节肝缺血/再灌注诱导的局部和远处器官炎症损伤。
Gastroenterology. 1999 Oct;117(4):953-61. doi: 10.1016/s0016-5085(99)70355-0.
5
Hypoxia down-regulates expression of secretory leukocyte protease inhibitor in bronchial epithelial cells via TGF-β1.缺氧通过转化生长因子-β1下调支气管上皮细胞中分泌型白细胞蛋白酶抑制剂的表达。
BMC Pulm Med. 2015 Mar 7;15:19. doi: 10.1186/s12890-015-0016-0.
6
Transforming growth factor-beta1 is a potent inhibitor of secretory leukoprotease inhibitor expression in a bronchial epithelial cell line. Munich Lung Transplant Group.转化生长因子-β1是支气管上皮细胞系中分泌性白细胞蛋白酶抑制剂表达的强效抑制剂。慕尼黑肺移植组。
Eur Respir J. 2000 Jun;15(6):1052-7. doi: 10.1034/j.1399-3003.2000.01513.x.
7
Up-regulation of Bcl-2 through hyperbaric pressure transfection of TGF-beta1 ameliorates ischemia-reperfusion injury in rat cardiac allografts.
J Heart Lung Transplant. 2002 Feb;21(2):244-50. doi: 10.1016/s1053-2498(01)00377-1.
8
Secretory leukocyte protease inhibitor modulates urethane-induced lung carcinogenesis.分泌白细胞蛋白酶抑制剂调节尿烷诱导的肺癌发生。
Carcinogenesis. 2014 Apr;35(4):896-904. doi: 10.1093/carcin/bgt382. Epub 2013 Nov 26.
9
[Effects of secretory leukocyte protease inhibitor on the production of some cytokines and nitric oxide by murine peritoneal macrophages in response to lipopolysaccharide stimulation and M. avium complex infection].[分泌型白细胞蛋白酶抑制剂对脂多糖刺激及鸟分枝杆菌复合群感染后小鼠腹腔巨噬细胞某些细胞因子产生及一氧化氮生成的影响]
Kekkaku. 1999 Jul;74(7):563-70.
10
Clusterin Reduces Cold Ischemia-Reperfusion Injury in Heart Transplantation Through Regulation of NF-kB Signaling and Bax/Bcl-xL Expression.凝集素通过调节NF-κB信号通路和Bax/Bcl-xL表达减轻心脏移植中的冷缺血-再灌注损伤。
Cell Physiol Biochem. 2018;45(3):1003-1012. doi: 10.1159/000487295. Epub 2018 Feb 5.

引用本文的文献

1
The secretory leukocyte protease inhibitor (SLPI) in pathophysiology of non-communicable diseases: Evidence from experimental studies to clinical applications.分泌型白细胞蛋白酶抑制剂(SLPI)在非传染性疾病病理生理学中的作用:从实验研究到临床应用的证据
Heliyon. 2024 Jan 17;10(2):e24550. doi: 10.1016/j.heliyon.2024.e24550. eCollection 2024 Jan 30.
2
Secretory leukocyte protease inhibitor and risk of heart failure in the Multi-Ethnic Study of Atherosclerosis.分泌型白细胞蛋白酶抑制剂与动脉粥样硬化多民族研究中心心力衰竭风险的关系。
Sci Rep. 2023 Jan 12;13(1):604. doi: 10.1038/s41598-023-27679-0.
3
Adeno-associated virus 9 vector-mediated cardiac-selective expression of human secretory leukocyte protease inhibitor attenuates myocardial ischemia/reperfusion injury.
腺相关病毒9载体介导的人分泌型白细胞蛋白酶抑制剂的心脏选择性表达减轻心肌缺血/再灌注损伤。
Front Cardiovasc Med. 2022 Aug 19;9:976083. doi: 10.3389/fcvm.2022.976083. eCollection 2022.
4
Reduced ELANE and SLPI expression compromises dental pulp cell activity.ELANE 和 SLPI 表达减少会损害牙髓细胞活性。
Cell Prolif. 2021 Nov;54(11):e13132. doi: 10.1111/cpr.13132. Epub 2021 Sep 27.
5
Adhesion pathway proteins and risk of atrial fibrillation in the Multi-Ethnic Study of Atherosclerosis.黏附途径蛋白与动脉粥样硬化多民族研究中心中心房颤动的风险。
BMC Cardiovasc Disord. 2021 Sep 14;21(1):436. doi: 10.1186/s12872-021-02241-w.
6
Post-Ischemic Treatment of Recombinant Human Secretory Leukocyte Protease Inhibitor (rhSLPI) Reduced Myocardial Ischemia/Reperfusion Injury.重组人分泌型白细胞蛋白酶抑制剂(rhSLPI)的缺血后治疗减轻了心肌缺血/再灌注损伤。
Biomedicines. 2021 Apr 13;9(4):422. doi: 10.3390/biomedicines9040422.
7
Transcriptome analysis defines myocardium gene signatures in children with ToF and ASD and reveals disease-specific molecular reprogramming in response to surgery with cardiopulmonary bypass.转录组分析定义了法洛四联症合并 ASD 患儿的心肌基因特征,并揭示了体外循环心脏手术后针对特定疾病的分子重编程。
J Transl Med. 2020 Jan 10;18(1):21. doi: 10.1186/s12967-020-02210-5.
8
Secretory Leukocyte Protease Inhibitor (SLPI)-A Novel Predictive Biomarker of Acute Kidney Injury after Cardiac Surgery: A Prospective Observational Study.分泌型白细胞蛋白酶抑制剂(SLPI)——心脏手术后急性肾损伤的一种新型预测生物标志物:一项前瞻性观察研究。
J Clin Med. 2019 Nov 9;8(11):1931. doi: 10.3390/jcm8111931.
9
Endothelial-Cell-Derived Human Secretory Leukocyte Protease Inhibitor (SLPI) Protects Cardiomyocytes against Ischemia/Reperfusion Injury.内皮细胞源性人分泌型白细胞蛋白酶抑制剂(SLPI)可保护心肌细胞免受缺血/再灌注损伤。
Biomolecules. 2019 Oct 31;9(11):678. doi: 10.3390/biom9110678.
10
Donor biomarkers as predictors of organ use and recipient survival after neurologically deceased donor organ transplantation.供体生物标志物作为神经死亡供体器官移植后器官使用和受体存活的预测指标。
J Crit Care. 2018 Dec;48:42-47. doi: 10.1016/j.jcrc.2018.08.013. Epub 2018 Aug 18.